Tampon Giants Merge, Israeli Market Faces Complications

The merger between the companies behind the Kotex, Carefree, and o.b. tampon brands has been approved in Israel, but with a significant condition: Kimberly-Clark must sell its local feminine hygiene operations. This decision stems from concerns about reduced competition and potential price increases for consumers.

Kimberly-Clark produces and markets disposable feminine hygiene products under the Kotex and Lily brands. Cannbio, which distributes its products in Israel, manufactures o.b. tampons and Carefree panty liners. Both companies also have broader product lines; Kimberly-Clark sells baby products, adult diapers, and paper goods, while Cannbio offers beauty and health items.

Without the divestiture, the merger would have consolidated two major players, leaving the market dominated by just two groups. This concentration of power raised fears that the merged entity could raise prices, and that remaining competitors might coordinate their strategies, leading to higher product costs.

To mitigate these risks, the Israeli regulator mandated that the divested operations be sold to an independent third party, subject to approval. The agreement with the buyer must be finalized before the international merger is completed. Conditions were also set to ensure the buyer can operate as a viable independent competitor.

This requirement for divestiture is not unique to Israel. Similar conditions were imposed during the merger's review in Europe, New Zealand, and Australia, where the approval of the merger was also contingent on the sale of feminine hygiene operations by one of the parties.